| Darunavir |
EU/1/06/380/007 |
PREZISTA, Film coated tablet, 800, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen – Cilag SpA, Италия |
694.16 |
138.83 |
832.99 |
4% |
10 |
704.16 |
140.83 |
844.99 |
16% |
25 |
729.16 |
145.83 |
874.99 |
|
НСР-6572/24.06.2015 |
10.07.2015 |
10.07.2015 |
Неактивен |
4025 |
| Darunavir |
0914/22.10.2007 |
PREZISTA, Film coated tablet, 800, mg, Pack: 30 |
Woerwag Pharma GmbH & Co.KG, Германия |
Artesan Pharma GmbH&Co.KG, Germany: Chanelle Medical, Ireland |
7.71 |
1.54 |
9.25 |
7% |
0.54 |
8.25 |
1.65 |
9.9 |
20% |
1.54 |
9.79 |
1.96 |
11.75 |
промяна на обстоятелства решение КЦ-3084/04.11.2011 |
КЦ-2987/14.10.2011 |
01.11.2011 |
01.11.2011 |
Неактивен |
4025 |
| Norethisterone |
9900329 |
PRIMOLUT-NOR-5, Tablet, 5, mg, Pack: 20 |
Bayer Pharma AG, Германия |
Bayer Pharma AG; Bayer Weimar GmbH & Co KG, Германия |
2.35 |
0.47 |
2.82 |
7% |
0.16 |
2.51 |
0.5 |
3.01 |
20% |
0.47 |
2.98 |
0.6 |
3.58 |
промяна в обстоятелствата HCP-5721/26.02.2015; корекционно решение НСР-8646/31.05.2016; цената е вписана в регистърна на пределните цени с решение НСР-8647/31.03.2016. (в сила от 02.05.2016) |
КЦ-353/19.12.2008 |
22.01.2009 |
22.01.2009 |
Заличен |
363 |
| Perindopril, Indapamide, Amlodipine |
20180099 |
Prindal, Tablet, 4 mg/1.25 mg/5 mg, -, Pack: 30 |
Zentiva k.s., Чешка република |
Zentiva k.s., Чешка република |
7.67 |
1.53 |
9.2 |
7% |
0.54 |
8.21 |
1.64 |
9.85 |
20% |
1.53 |
9.74 |
1.95 |
11.69 |
|
НСР-16458/17.08.2018 |
01.09.2018 |
02.09.2018 |
Активен |
16209 |
| Perindopril, Indapamide, Amlodipine |
20180100 |
Prindal, Tablet, 8 mg/2.5 mg/5 mg, -, Pack: 30 |
Zentiva k.s., Чешка република |
Zentiva k.s., Чешка република |
11.07 |
2.21 |
13.28 |
6% |
0.66 |
11.73 |
2.35 |
14.08 |
18% |
1.99 |
13.72 |
2.74 |
16.46 |
|
НСР-16458/17.08.2018 |
01.09.2018 |
02.09.2018 |
Активен |
16210 |
| Perindopril, Indapamide |
II-14879/ 15.09.2011 |
Prindex plus, Tablet, 4 mg/ 1,25 mg, mg, Pack: 30 |
Glenmark Pharmaceuticals s.r.o., Чешка република |
Glenmark Pharmaceuticals s.r.o., Belohorska 39/260, 169 00 Praha 6, Fibichova 143 566 17 Vysoke Myto, Чехия |
6.57 |
1.31 |
7.88 |
7% |
0.46 |
7.03 |
1.41 |
8.44 |
20% |
1.31 |
8.34 |
1.67 |
10.01 |
Цената се заличава с решение НСР-2115/11.12.2013 |
КЦРР-1720/28.11.2012 |
13.12.2012 |
13.12.2012 |
Заличен |
1467 |
| Perindopril |
20140021 |
Prinopril, Tablet, 8, mg, Pack: 30 |
Унифарм АД, България |
Унифарм АД, България |
6.98 |
1.4 |
8.38 |
7% |
0.49 |
7.47 |
1.49 |
8.96 |
20% |
1.4 |
8.87 |
1.77 |
10.64 |
|
НСР-3032/21.03.2014 |
08.04.2014 |
08.04.2014 |
Активен |
2616 |
| Perindopril |
20140022 |
Prinopril, Tablet, 4, mg, Pack: 30 |
Унифарм АД, България |
Унифарм АД, България |
3.49 |
0.7 |
4.19 |
7% |
0.24 |
3.73 |
0.75 |
4.48 |
20% |
0.7 |
4.43 |
0.89 |
5.32 |
|
НСР-3032/21.03.2014 |
08.04.2014 |
08.04.2014 |
Активен |
2617 |
| Measles, mumps and rubella vaccine (live) |
II-3035 / 18.09.2008 г. |
Priorix, Powder and solvent for suspension for injection, 1 dose 0.5 ml, -, Pack: 1 vial with powder + 1 pre-filled syr. 0,5 ml solv + 2 separate needles |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
14.96 |
2.99 |
17.95 |
6% |
0.9 |
15.86 |
3.17 |
19.03 |
18% |
2.69 |
18.55 |
3.71 |
22.26 |
|
КЦРР-718/07.06.2012 |
26.06.2012 |
26.06.2012 |
Активен |
1234 |
| Measles, mumps and rubella vaccine (live) |
9800351 |
Priorix, Powder and solvent for suspension for injection, 1 dose 0.5 ml, -, Pack: 1 vial with powder + 1 ampoule with solvent |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l’Institut 89, 1330 Rixensart, Белгия |
14.67 |
2.93 |
17.6 |
6% |
0.88 |
15.55 |
3.11 |
18.66 |
18% |
2.64 |
18.19 |
3.64 |
21.83 |
|
НСР-7216/15.10.2015. |
30.10.2015 |
30.10.2015 |
Активен |
4084 |
| Measles, mumps and rubella vaccine (live) |
9800351 |
Priorix, Powder and solvent for suspension for injection, 1 dose 0.5 ml, -, Pack: 100 vial with powder + 100 ampoule with solvent |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l’Institut 89, 1330 Rixensart, Белгия |
1550 |
310 |
1860 |
4% |
10 |
1560 |
312 |
1872 |
16% |
25 |
1585 |
317 |
1902 |
|
НСР-8093/17.02.2016. (допуска предварително изпълнение) |
17.02.2016 |
17.02.2016 |
Активен |
4184 |
| Measles, mumps and rubella vaccine (live) |
II-3035/18.09.2008 |
Priorix, Powder and solvent for suspension for injection, Live attenuated measles virus (Schwarz strain) 1; Live attenuated mumps virus (RIT 4385 strain) 1; Live attenuated rubella virus (Wistar RA 27/3 strain) 1, -, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, Belgium |
14.67 |
2.93 |
17.6 |
6% |
0.88 |
15.55 |
3.11 |
18.66 |
18% |
2.64 |
18.19 |
3.64 |
21.83 |
цената се заличава КЦРР-1642/15.11.2012 |
КЦ-1274/29.12.2009 |
17.01.2010 |
17.01.2010 |
Заличен |
855 |
| Measles, mumps and rubella vaccine (live) |
II-3035 / 18.09.2008 г. |
Priorix, Powder and solvent for solution for injection, Live attenuated measles virus (Schwarz strain) 1; Live attenuated mumps virus (RIT 4385 strain) 1; Live attenuated rubella virus (Wistar RA 27/3 strain) 1, mg, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
19.32 |
3.86 |
23.18 |
8% |
1.55 |
20.87 |
4.17 |
25.04 |
20% |
3.86 |
24.73 |
4.95 |
29.68 |
корекционна КЦ-1087/13.08.2009 |
КЦ-704/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
1234 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
372.98 |
74.6 |
447.58 |
4% |
10 |
382.98 |
76.6 |
459.58 |
16% |
25 |
407.98 |
81.6 |
489.58 |
|
НСР-7188/09.10.2015.; НСР-11147/08.12.2016; НСР-15139/02.03.2018 |
17.03.2018 |
02.04.2018 |
Активен |
2007 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
375.71 |
75.14 |
450.85 |
4% |
10 |
385.71 |
77.14 |
462.85 |
16% |
25 |
410.71 |
82.14 |
492.85 |
|
НСР-7188/09.10.2015.; НСР-11147/08.12.2016 |
24.12.2016 |
02.01.2017 |
Неактивен |
2007 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
732.95 |
146.59 |
879.54 |
4% |
10 |
742.95 |
148.59 |
891.54 |
16% |
25 |
767.95 |
153.59 |
921.54 |
|
НСР-7189/09.10.2015.; НСР-11148/08.12.2016 г.; НСР-15140/02.03.2018 |
17.03.2018 |
02.04.2018 |
Активен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
752.35 |
150.47 |
902.82 |
4% |
10 |
762.35 |
152.47 |
914.82 |
16% |
25 |
787.35 |
157.47 |
944.82 |
|
НСР-7189/09.10.2015.; НСР-11148/08.12.2016 г. |
24.12.2016 |
02.01.2017 |
Неактивен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
187.43 |
37.49 |
224.92 |
4% |
7.5 |
194.93 |
38.99 |
233.92 |
16% |
25 |
219.93 |
43.99 |
263.92 |
|
НСР-7187/09.10.2015.; НСР-11146/08.12.2016; НСР-15138/02.03.2018 |
17.03.2018 |
02.04.2018 |
Активен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
190.18 |
38.04 |
228.22 |
4% |
7.61 |
197.79 |
39.56 |
237.35 |
16% |
25 |
222.79 |
44.56 |
267.35 |
|
НСР-7187/09.10.2015.; НСР-11146/08.12.2016 |
24.12.2016 |
02.01.2017 |
Неактивен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
759.94 |
151.99 |
911.93 |
4% |
10 |
769.94 |
153.99 |
923.93 |
16% |
25 |
794.94 |
158.99 |
953.93 |
|
НСР-7189/09.10.2015. |
24.10.2015 |
24.10.2015 |
Неактивен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
194.45 |
38.89 |
233.34 |
4% |
7.78 |
202.23 |
40.45 |
242.68 |
16% |
25 |
227.23 |
45.45 |
272.68 |
|
НСР-7187/09.10.2015. |
24.10.2015 |
24.10.2015 |
Неактивен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
379.63 |
75.93 |
455.56 |
4% |
10 |
389.63 |
77.93 |
467.56 |
16% |
25 |
414.63 |
82.93 |
497.56 |
|
НСР-7188/09.10.2015. |
24.10.2015 |
24.10.2015 |
Неактивен |
2007 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
790.55 |
158.11 |
948.66 |
4% |
10 |
800.55 |
160.11 |
960.66 |
16% |
25 |
825.55 |
165.11 |
990.66 |
|
НСР-155/18.06.2013 |
15.08.2013 |
15.08.2013 |
Неактивен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
197.64 |
39.53 |
237.17 |
4% |
7.91 |
205.55 |
41.11 |
246.66 |
16% |
25 |
230.55 |
46.11 |
276.66 |
|
НСР-154/18.06.2013 |
15.08.2013 |
15.08.2013 |
Неактивен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
395.27 |
79.05 |
474.32 |
4% |
10 |
405.27 |
81.05 |
486.32 |
16% |
25 |
430.27 |
86.05 |
516.32 |
|
НСР-212/20.06.2013 |
15.08.2013 |
15.08.2013 |
Неактивен |
2007 |